To build and advance the supply chain of this nascent medical science by

• promoting collaboration among the emerging stakeholders;
• creating a platform for exchange of business knowledge and experience;
• fostering commercialization and scaling up of CAR-T Cell Therapy;
• incorporating agility, accountability, quality and integrity in the business end-to-end;
• and enabling the delivery of affordable healthcare in the long run.

The Supply Chain challenges are truly Draconian with the production batch size of one, where the environment of temperature control, chain of custody, overall product and process  integrity, and reliability of supply of manufacturing materials is demanding. It is an unprecedented challenge for science and business to come together.